Evidence map›Paper›PMID 33512994›Full record

ArticleJournal of the American Society for Mass Spectrometry2021

Comprehensive Quantification of Carboxymethyllysine-Modified Peptides in Human Plasma.

Arvind M Korwar, Qibin Zhang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Plasma/Serum Proteomics based on Mass Spectrometry.Protein and peptide letters · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Arvind M KorwarCenter for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States.
Qibin ZhangCenter for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States.ORCID http://orcid.org/0000-0002-6135-8706
University of North Carolina at Greensboro · US

Funding

Protein Markers to Islet Autoimmunity and T1D ProgressionR01DK114345 · NIDDK · UNIVERSITY OF NORTH CAROLINA GREENSBORO · PI ZHANG, QIBIN · 2017 to 2022
$1.7M
Discovery and validation of biomarkers of cardiovascular complications in type 1 diabetesR01DK116731 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI SNELL-BERGEON, JANET KATHLEEN, ZHANG, QIBIN · 2018 to 2020
$1.1M
NIDDK NIH HHS R01 DK114345NIDDK NIH HHS R01 DK116731
6 · The paper itself

Abstract

A prolonged hyperglycemic condition in diabetes mellitus results in glycation of plasma proteins.

Indexed as

Diabetes Mellitus, Type 1Glycation End Products, AdvancedGlycosylationHumansLysinePeptide LibraryPeptidesTandem Mass SpectrometryGlycation End Products, AdvancedLysineN(6)-carboxymethyllysinePeptide LibraryPeptidesAmadori modified lysinecarboxymethyllysineglycemic controlparallel reaction monitoringprotein glycationType 1 diabetes

Identifiers

PMID33512994
PMCPMC8075102
OpenAlexW3124944010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.